Ischaemic stroke following tranexamic acid in young patients carrying heterozygosity of MTHFR C677T

Annals of Clinical Biochemistry

Volumn 48, Issue 6, 2011, Pages 575-578

  Nardi, Katiuscia ^a   Pelone, Giordana ^a   Bartolo, Michelangelo ^a   Di Ruzza, Maria Rita ^a   Storto, Marianna ^a   Notte, Antonella ^a   Grillea, Giovanni ^a   Colonnese, Claudio ^a   Lembo, Giuseppe ^a,b   Vecchione, Carmine ^a  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; TRANEXAMIC ACID;

ADULT; ANOSOGNOSIA; APHASIA; ARTICLE; BLEEDING; BLOOD CLOTTING; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; BRAIN ISCHEMIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DYSARTHRIA; ELECTROCARDIOGRAPHY; FEMALE; GENETIC ANALYSIS; GYNECOLOGIC DISEASE; HEMIPLEGIA; HEREDITY; HETEROZYGOSITY; HUMAN; INTERNAL CAROTID ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THROMBOPHILIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION;

ADULT; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MIDDLE CEREBRAL ARTERY; MUTATION, MISSENSE; TRANEXAMIC ACID;

EID: 84856005872     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2011.011101     Document Type: Article

References (17)

1. Pezzini A, Grassi M, Del Zotto E, et al. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke 2005;36:533-9
2. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 2003;146:948-57
3. Frederiksen J, Juul K, Grande P, et al. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case control studies from the Copenhagen City Heart Study. Blood 2004;104:3046-51
4. Pezzini A, Grassi M, Del Zotto E, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke 2007;38:3145-51
5. Ferro JM, Massaro AR, Mas JL. Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol 2010;9:1085-96
6. Linetsky E, Leker RR, Ben-Hur T. Headache characteristics in patients after migrainous stroke. Neurology 2001;57:130-2
7. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;(4):CD000249
8. Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 2003;63:1417-33
9. Kagstrom E, Palma L. Influence of antifibrinolytic treatment on the morbidity in patients with subarachnoid hemorrhage. Acta Neurol Scand 1972;48:257-8
10. Sonntag VKH, Stein BM. Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid. J Neurosurg 1974;40:480-5
11. Rydin E, Lundberg PO. Tranexamic acid and intracranial thrombosis. Lancet 1976;2:49
12. Davies D, Howell DA. Tranexamic acid and arterial thrombosis. Lancet 1977;1:49
13. Levati A, Minella C, Farina ML, D'Angelo V. Potential hazards of antifibrinolytic treatment in subarachnoid haemorrhage. Thromb Haemost 1980;44:170-1
14. Beller FK. Treatment of coagulation disorders in pregnancy. Clin Obstet Gynecol 1964;7:372-89
15. Immergut MA, Stevenson T. The use of epsilon amino caproic acid in the control of hematuria associated with hemoglobinopathies. J Urol 1965;93:110-1
16. Agnelli G, Gresele P, De Cunto M, et al. Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Br J Obstet Gynaecol 1982;89:681-2
17. Antoniades C, Shirodaria C, Leeson P, et al. MTHFR 677 C.T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 2009;119:2507-15